Anzeige
Mehr »
Login
Freitag, 17.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Dow Jones News
278 Leser
Artikel bewerten:
(1)

Hardman & Co Announcement: Blackbird presenting at the October Investor Forum 'Shareholder value in ESG investing' on 4 October 2022

Finanznachrichten News

DJ Hardman & Co Announcement: Blackbird presenting at the October Investor Forum 'Shareholder value in ESG investing' on 4 October 2022

Hardman & Co Research Hardman & Co Announcement: Blackbird presenting at the October Investor Forum 'Shareholder value in ESG investing' on 4 October 2022 22-Sep-2022 / 14:20 GMT/BST

-----------------------------------------------------------------------------------------------------------------------

Blackbird presenting at the October Investor Forum 'Shareholder value in ESG investing' on 4 October 2022

The green economy - a new growth market

We are delighted to announce Blackbird plc will be presenting alongside CyanConnode Holdings plc and Gore Street Energy Storage Fund plc in the forthcoming October Investor Forum: 'Shareholder value in ESG Investing', jointly hosted by the London Stock Exchange and Hardman & Co. The forum will take place on Tuesday 4 October 2022 at 3:00pm as an online virtual webinar.

Selected from the London Stock Exchange's Green Economy Mark Report 2022, the presenters are amongst the cohort of recognised London-listed companies and funds driving the global green economy and supporting the shift towards a low-carbon economy. Join us to hear each company present on their business followed by an audience-led Q&A session. There will be a lively panel debate with all three management teams on 'shareholder value in ESG investing', opening to a Q&A session with the audience thereafter.

Don't miss the opportunity to join the discussion: register now for your place.

Blackbird plc engages in the development and commercial exploitation of cloud-based video technology. The firm offers products under the brands of Forscene and CAPTEVATE. It serves broadcasting, professional Web video, education, and consumers markets. The company was founded by Stephen B. Streater in 1998 and is headquartered in London.

If you are interested in attending the virtual forum, you can register your interest by clicking on the above link.

To contact us: 
Hardman & Co            Contact: 
35 New Broad Street 
London               Larissa Adams 
EC2M 1NH                      la@hardmanandco.com 
                  +44 20 7194 7622 
www.hardmanandco.com 
Follow us on Twitter @HardmanandCo 

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.

-----------------------------------------------------------------------------------------------------------------------

Dissemination of a CORPORATE NEWS, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.

-----------------------------------------------------------------------------------------------------------------------

End of Announcement - EQS News Service

1448643 22-Sep-2022

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1448643&application_name=news

(END) Dow Jones Newswires

September 22, 2022 09:20 ET (13:20 GMT)

© 2022 Dow Jones News
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.